Jill Scott
Psychiatric/Mental Health · Anoka, MNNPI 1124428222
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 358 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 358 payments — averaging $14.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$951
- AbbVie$946
- Corium, LLC$447
- Alkermes, Inc.$446
- Johnson & Johnson$436
- Otsuka America Pharmaceutical, Inc.$400
- plus $2K from 14 others
What the payments were for
- Food & beverage$5,08899%
- Education$591%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,147 in reported general payments places this provider in the 95th percentile of 407 psychiatric/mental health providers in Minnesota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 15 | $20,989 |
| TrintellixVortioxetine Hydrobromide | 28 | $20,087 |
| Bupropion XlBupropion Hcl | 139 | $3,215 |
| Aripiprazole | 36 | $2,725 |
| Escitalopram Oxalate | 108 | $1,933 |
| Buspirone Hcl | 73 | $1,215 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 70 | $1,100 |
| Alprazolam | 136 | $995 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 16 | $837 |
| Doxepin Hcl | 19 | $798 |
| Imipramine Hcl | 36 | $757 |
| Trazodone Hcl | 92 | $638 |
| Duloxetine Hcl | 18 | $438 |
| Triazolam | 12 | $371 |
| Sertraline Hcl | 61 | $334 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $946 | $20,98915 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $25 | $20,08728 claims |
| Almatica Pharma LLCSertraline Hcl | $97 | $33461 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 407 psychiatric/mental health providers in Minnesota.
Other psychiatric/mental health in Anoka
- Patrick DixonAnoka$3K
- Jacqualine GervaisMoorhead$29K
- Naomi KoenigSandstone$8K
- Dana BageonWayzata$7K
- Holly WillisMinneapolis$5K
- Gerard BalanMinneapolis$5K
- Hilary BreedonShakopee$3K
- Tina AlexanderEdina$3K
- Twilla OskeyBaxter$3K
- Sara OckerCambridge$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.